Both in Biotechnology
Outlook Therapeutics vs Voyager Therapeutics
Over the past year OTLK returned −64.6% and VYGR returned −60.1%; their daily moves had a correlation of 0.09.
OTLK −64.6% VYGR −60.1%Growth of $1, one year, split-adjusted
| Metric | OTLK | VYGR |
|---|---|---|
| Price | $0.4600 | $1.83 |
| Market cap | $112.0M | $112.8M |
| Today | −1.96% | +2.81% |
| 1 month | −22.8% | −25.6% |
| 6 months | +90.3% | −53.1% |
| Year to date | −70.9% | −53.4% |
| 1 year | −63.5% | −60.8% |
| Revenue growth (YoY) | −99.4% | −39.1% |
| Gross margin | −95.0% | 100.0% |
| Net margin | −233554.9% | −773.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.3× |
| Net cash | -$7.0M | $116.3M |
| Dividend yield | — | — |
| Volatility (60d) | 89.0% | 60.9% |
| Short % of float | 39.3% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).